Article
MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma
29 May 2024
Abstract excerpt
Radiotherapy is the standard treatment for glioblastoma (GBM), but the overall survival rate for radiotherapy treated GBM patients is poor. The use of adjuvant and concomitant temozolomide (TMZ) improves the outcome; however, the effectiveness of this treatment varies according to MGMT levels. Herein, we evaluated whether MGMT expression affected the radioresponse of human GBM, GBM stem-like cells (GSCs), and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
